These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11682068)

  • 1. Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins.
    Wurch T; Matsumoto A; Pauwels PJ
    FEBS Lett; 2001 Oct; 507(1):109-13. PubMed ID: 11682068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.
    Gazi L; López-Giménez JF; Rüdiger MP; Strange PG
    Eur J Biochem; 2003 Oct; 270(19):3928-38. PubMed ID: 14511374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB.
    Cook JL; Re R; Alam J; Hart M; Zhang Z
    J Mol Cell Cardiol; 2004 Jan; 36(1):75-90. PubMed ID: 14734050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
    Wurch T; Boutet-Robinet EA; Palmier C; Colpaert FC; Pauwels PJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
    Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor.
    Pregenzer JF; Alberts GL; Im WB
    Neurosci Lett; 1997 Apr; 226(2):91-4. PubMed ID: 9159497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological analysis of a dopamine D(2Short):G(alphao) fusion protein expressed in Sf9 cells.
    Gazi L; Wurch T; Lopéz-Giménez JF; Pauwels PJ; Strange PG
    FEBS Lett; 2003 Jun; 545(2-3):155-60. PubMed ID: 12804767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation.
    Quirk K; Roberts DJ; Strange PG
    Br J Pharmacol; 2007 May; 151(1):144-52. PubMed ID: 17351658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the ligand binding and signaling properties of human dopamine D(2) and D(3) receptors in Chinese hamster ovary cells.
    Vanhauwe JF; Fraeyman N; Francken BJ; Luyten WH; Leysen JE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):908-16. PubMed ID: 10411608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
    Wilson J; Lin H; Fu D; Javitch JA; Strange PG
    J Neurochem; 2001 Apr; 77(2):493-504. PubMed ID: 11299312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner.
    Pauwels PJ; Tardif S; Colpaert FC
    Biochem Pharmacol; 2001 Sep; 62(6):723-32. PubMed ID: 11551517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo reconstitution of dopamine D2S receptor-mediated G protein activation in baculovirus-infected insect cells: preferred coupling to Gi1 versus Gi2.
    Grünewald S; Reiländer H; Michel H
    Biochemistry; 1996 Dec; 35(48):15162-73. PubMed ID: 8952463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype.
    Cordeaux Y; Nickolls SA; Flood LA; Graber SG; Strange PG
    J Biol Chem; 2001 Aug; 276(31):28667-75. PubMed ID: 11369753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
    Roberts DJ; Lin H; Strange PG
    Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments.
    Scarselli M; Armogida M; Chiacchio S; DeMontis MG; Colzi A; Corsini GU; Maggio R
    Eur J Pharmacol; 2000 Jun; 397(2-3):291-6. PubMed ID: 10844126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2011 Sep; 666(1-3):43-52. PubMed ID: 21658377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.